IL6 and type 2 diabetes mellitus: IM patients with type 2 diabetes (main group) have a 2.7 times increase in CRP content, 4.4 and 3.1 times in proinflammatory IL-6 and TNF-α, respectively, as well as anti-inflammatory IL-10 concentration of 1.9 times higher relative to the indicators in the control group.